ft 08 feb 94 technolog delay cut stroke pen comput stylu could shorten trial period pharmaceut compani time money intern pharmaceut compani delay get blockbust compound market give rival time launch price cut imit day hold cost drug compani dollar 1m pound 600 000 lost revenu result race bring latest comput technolog cut approv time clinic trial particular target big pharmaceut compani mani big drug compani invest person comput facsimil machin rhone poulenc rorer us gone one step conduct trial pen comput electron tablet reminisc victorian school slate stylu pen use write screen softwar usual display form box tick fill eventu pen base machin could obviat mountain paperwork associ drug trial case record form complet triplic 2cm thick one patient typic trial would involv three phase averag 200 patient per trial rhone poulenc rorer part rhone poulenc franc use pen comput trial antibiot began last decemb 30 40 site involv eight use pen comput duplic paper system aim say greg fromel associ director clinic research us assess much quicker electron system could fromel see two big area time save first data entri transfer paper base test result comput alway bottleneck data often type two three time introduc error delay pen comput inform enter screen transfer directli main databas second research lose month correct basic error paper data softwar select rhone poulenc rorer german compani padcom help elimin number requir respons specif question softwar allow doctor enter letter tick softwar check birth date patient ensur appropri age take part studi queri inform appear outsid like boundari unlik paper questionnair although fromel believ breakthrough creation comput take handwritten inform compani grid ncr tandi ibm us nec toshiba japan argu hardwar provid competit edg drug trial softwar casella hoechst subsidiari frankfurt clinic project manag dieter r dannhorn believ critic softwar guid doctor mani inexperienc use comput form need doctor happi system otherwis go get patient trial casella alreadi conduct short clinic trial pen comput 16 patient plan clinic trial anti fungal product involv 240 patient 10 centr patient question three time doctor involv receiv diskett complet patient visit rhone poulenc rorer trial diskett also use record patient inform post central offic data enter databas futur data could sent automat phone line drug compani believ earli predict potenti save padcom director market peter munzel calcul typic phase ii trial drug test efficaci first time save could 40 per cent 10 centr 200 patient involv 12 month period patient visit doctor six time munzel calcul save dollar 205 000 total studi cost dollar 511 440 reduc number queri need retyp argu pen comput use throughout drug approv procedur could cut month studi averag 30 studi per drug could cut month even year eight 12 year usual take get drug approv give compani extra two three year sale compound competitor flood market everyon optimist challeng make major improv whole host area say mark delfino manag specialis inform technolog boston consult group chicago pen base system per se friendli interfac easier way get data data come still need set process handl quickli although pen comput save time data entri dannhorn calcul unfamiliar write case studi book pen pc mean take five time long write one pen comput paper base trial drug compani could drawn write much softwar need set expens centr technic expertis add delfino addit cost hardwar inconsequenti reckon cost dollar 5 000 dollar 20 000 per site equip trial site machin today pen comput often rel heavi short batteri life far de facto oper system compani favour develop silicon valley start go other prefer microsoft window pen comput pharmaceut compani quick adopt pen comput other strong reserv one concern handwrit recognit technolog still rel primit one biggest problem legibl doctor notori bad handwrit say stephen hill uk medic director roch swiss pharmaceut compani fear data could inaccur record particularli intern trial conduct english english first languag doctor involv one biggest problem make sure inform collect match inform patient record continu hill data enter directli pc doctor surgeri compani main databas without intermediari check mistak could slip regulatori issu also hamper widespread take system pfizer uk oper sandwich kent exampl research still wait pronounc us food drug administr use electron signatur paper trial investig doctor sign trial result valid guidelin electron signatur germani system even restrict although inform casella trial record screen german law requir result trial print sign doctor trial valid glaxo uk research experi pen base comput believ anoth two three year reli utterli say spokesman glaxo voic recognit technolog doctor simpli talk machin could made similar advanc might becom domin technolog